# Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells

> **NCT05675982** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Centre Henri Becquerel** · enrollment: 40 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **OTHER:** CAR-T cells monitoring

## Key facts

- **NCT ID:** NCT05675982
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-13
- **Primary completion:** 2025-09-08
- **Final completion:** 2026-09-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05675982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05675982, "Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05675982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*